glp-1 alzheimer's study A doctor explains why weight loss medications may do more than change the scale—early research suggests they could sharply cut risk by easing inflammation and protecting the brain Frontiers | Semaglutide in cognitive

Is it possible that were learning to spray our cravings instead of chewing them

While the findings show promise for treating alcohol use disorder, the researchers say that more rigorous studies are needed

Further investigations are therefore needed to clarify the potency of l-valine (and other amino acids) in stimulating GLP-1 release in humans and to investigate the postprandial effect of l-valine on blood glucose regulation when given as a preload before a carbohydrate-containing meal

Data from nationwide registers from Sweden, Denmark and Norway showed that patients initiating SGLT-2i were less likely to develop renal adverse events, such as RRT, hospitalization, or death for renal causes, compared to GLP-1RA users [37]

Curr Opin Cell Biol 16 , 162168, (2004)